Studies on the Effect of Maternal Pre‐eclamptic Toxaemia on Placental Weight and on Head Size and Birth Weight of the Newborn

Abstract

Summary The influence of pre‐eclamptic toxaemia (PET) on head size and birth weight of newborn infants and placental weight was studied in single live births after 35 to 42 weeks gestation from mothers with or without toxaemia. There were no significant differences in the distribution of mean birth weight, head size, placental weight, head size/birth weight ratio or placental weight/birth weight ratio between the toxaemic and non‐toxaemic groups. There were significant differences between toxaemic and non‐toxaemic mothers as regards parity, height and smoking habits. Since such maternal characteristics influence birth weights a correction was applied for them. The influence of maternal mid‐term weight and sex of the infants was also taken into account. No significant differences in corrected birth weights, between toxaemic and non‐toxaemic groups were detected on further analysis. It is suggested that the present obstetric management has prevented the retarding effect of pre‐eclamptic toxaemia on fetal and placental growth by reducing the severity and duration of the illness.

Fetal sex and maternal risk of pre‐eclampsia/eclampsia: a systematic review and meta‐analysis

“…Twenty‐two studies were included in this analysis, yielding data on 3 163 735 women . Table S1 summarises the characteristics of the included studies.…”

Maternal risk factors for abnormal placental growth: The national collaborative perinatal project

“…Multi-dimensional measures of placental growth may provide further insight into the understanding of underlying mechanisms of fetal adaptation and the gestational intervals in which these processes occur. For example, lateral growth of the chorionic plate plateaus in the middle of the third trimester, while thickness of the placenta increases primarily between 30 and 32 weeks gestation [ 9 ].…”